Plain-English translation of NCT06475261 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying whether low oxygen levels in muscle tissue during ovarian cancer surgery predict kidney damage afterward. During your cytoreductive surgery with hyperthermic intraperitoneal chemotherapy, doctors will measure oxygen levels in your muscle using a non-invasive device. The goal is to understand the link between these oxygen measurements and kidney function in the days after your operation.
Some patients develop kidney problems after this type of major cancer surgery, but doctors don't yet know which patients are at highest risk. This study aims to identify a simple, early warning sign—low muscle oxygen during surgery—that might help doctors prevent or manage kidney complications.
You likely qualify if…
You likely don't qualify if…
You would have your standard ovarian cancer surgery with heated chemotherapy as planned. During the operation, a small sensor will be placed on your muscle to continuously measure oxygen levels—this is a routine addition that doesn't change your surgery. After surgery, doctors will monitor your kidney function through blood tests on days 1 through 7 after your operation. No extra visits or procedures beyond your normal post-operative care are required.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Italy